/Boston%20Scientific%20sign%20at%20manufacturer%20of%20medical%20devices%20Silicon%20Valley%20office%20By%20MichaelVi.jpeg)
Valued at a market cap of $63.5 billion, Boston Scientific Corporation (BSX) is a global medical technology company headquartered in Marlborough, Massachusetts. It develops, manufactures, and markets innovative medical devices used to diagnose and treat a wide range of medical conditions. Its products support minimally invasive procedures across cardiovascular care, electrophysiology, neuromodulation, endoscopy, urology, and oncology.
The medtech titan is expected to announce its fiscal Q3 earnings before the market opens on Wednesday, Oct. 28. Before this event, analysts expect this healthcare company to report a profit of $0.76 per share, up 1.3% from $0.75 per share in the year-ago quarter. The company has topped or met Wall Street’s bottom-line estimates in each of the last four quarters.
